Back
ClearPoint Neuro Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
38
CLPT
ClearPoint Neuro
Last Price:
$13.19
Seasonality Move:
-12.7%
Buy
60
ALNY
Alnylam Pharmaceuticals
Last Price:
$280.77
Seasonality Move:
3.3%
Sell
38
ClearPoint Neuro (CLPT)
is a Sell
Is ClearPoint Neuro a Buy, Sell or Hold?
-
The current ClearPoint Neuro [CLPT] share price is $13.78. The Score for CLPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
CLPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CLPT Stock Price Chart
What is ClearPoint Neuro's stock price today?
-
The ClearPoint Neuro share price today is $13.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLPT is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $290.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
CLPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.56 | Buy |
Relative Strength Index (14 RSI): | 45.48 | Sell |
Chaikin Money Flow: | -51823 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.73 - 16.85) | Sell |
Bollinger Bands (100): | (12.36 - 17.02) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.72 | Buy |
Relative Strength Index (14 RSI): | 71.41 | Buy |
Chaikin Money Flow: | -979016 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.44 - 263) | Buy |
Bollinger Bands (100): | (240.32 - 271.8) | Buy |
CLPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.3 | Buy |
20-day SMA: | 13.96 | Sell |
50-day SMA: | 15.9 | Sell |
200-day SMA: | 11.92 | Buy |
8-day EMA: | 7.21 | Buy |
20-day EMA: | 3.53 | Buy |
50-day EMA: | 1.54 | Buy |
200-day EMA: | 0.4 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 257.74 | Buy |
20-day SMA: | 249.75 | Buy |
50-day SMA: | 257.54 | Buy |
200-day SMA: | 251.5 | Buy |
8-day EMA: | 263.89 | Buy |
20-day EMA: | 256.08 | Buy |
50-day EMA: | 255.39 | Buy |
200-day EMA: | 243.44 | Buy |
ClearPoint Neuro Earnings Growth & CLPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.02 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
ClearPoint Neuro Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |